BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

830 related articles for article (PubMed ID: 32766815)

  • 21. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.
    Webb GJ; Marjot T; Cook JA; Aloman C; Armstrong MJ; Brenner EJ; Catana MA; Cargill T; Dhanasekaran R; García-Juárez I; Hagström H; Kennedy JM; Marshall A; Masson S; Mercer CJ; Perumalswami PV; Ruiz I; Thaker S; Ufere NN; Barnes E; Barritt AS; Moon AM
    Lancet Gastroenterol Hepatol; 2020 Nov; 5(11):1008-1016. PubMed ID: 32866433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inpatient COVID-19 outcomes in solid organ transplant recipients compared to non-solid organ transplant patients: A retrospective cohort.
    Avery RK; Chiang TP; Marr KA; Brennan DC; Sait AS; Garibaldi BT; Shah P; Ostrander D; Steinke SM; Permpalung N; Cochran W; Makary MA; Garonzik-Wang J; Segev DL; Massie AB
    Am J Transplant; 2021 Jul; 21(7):2498-2508. PubMed ID: 33284498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunosuppression in solid organ transplant recipients with Covid-19: More data, but still complicated.
    Heldman MR; Kates OS; Fisher CE; Limaye AP
    Transpl Infect Dis; 2021 Aug; 23(4):e13650. PubMed ID: 34325492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence and Outcomes Associated With Clostridioides difficile Infection in Solid Organ Transplant Recipients.
    Hosseini-Moghaddam SM; Luo B; Bota SE; Husain S; Silverman MS; Daneman N; Brown KA; Paterson JM
    JAMA Netw Open; 2021 Dec; 4(12):e2141089. PubMed ID: 34964852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hospitalization and survival of solid organ transplant recipients with coronavirus disease 2019: A propensity matched cohort study.
    Swan JT; Rizk E; Jones SL; Nwana N; Nicolas JC; Tran AT; Xu J; Nisar T; Menser T; Yi SG; Moore LW; Huang HJ; Ghobrial RM; Gaber AO; Knight RJ
    PLoS One; 2022; 17(12):e0278781. PubMed ID: 36534667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The risk and consequences of breakthrough SARS-CoV-2 infection in solid organ transplant recipients relative to non-immunosuppressed controls.
    Vinson AJ; Anzalone AJ; Sun J; Dai R; Agarwal G; Lee SB; French E; Olex A; Ison MG; Mannon RB;
    Am J Transplant; 2022 Oct; 22(10):2418-2432. PubMed ID: 35674237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inpatient Mortality Among Solid Organ Transplant Recipients Hospitalized for Sepsis and Severe Sepsis.
    Donnelly JP; Locke JE; MacLennan PA; McGwin G; Mannon RB; Safford MM; Baddley JW; Muntner P; Wang HE
    Clin Infect Dis; 2016 Jul; 63(2):186-94. PubMed ID: 27217215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First experience of SARS-CoV-2 infections in solid organ transplant recipients in the Swiss Transplant Cohort Study.
    Tschopp J; L'Huillier AG; Mombelli M; Mueller NJ; Khanna N; Garzoni C; Meloni D; Papadimitriou-Olivgeris M; Neofytos D; Hirsch HH; Schuurmans MM; Müller T; Berney T; Steiger J; Pascual M; Manuel O; van Delden C;
    Am J Transplant; 2020 Oct; 20(10):2876-2882. PubMed ID: 32412159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severity of COVID-19 among solid organ transplant recipients in Canada, 2020-2021: a prospective, multicentre cohort study.
    Hall VG; Solera JT; Al-Alahmadi G; Marinelli T; Cardinal H; Poirier C; Huard G; Prasad GVR; De Serres SA; Isaac D; Mainra R; Lamarche C; Sapir-Pichhadze R; Gilmour S; Humar A; Kumar D
    CMAJ; 2022 Aug; 194(33):E1155-E1163. PubMed ID: 36302101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Between fear and courage: Attitudes, beliefs, and behavior of liver transplantation recipients and waiting list candidates during the COVID-19 pandemic.
    Reuken PA; Rauchfuss F; Albers S; Settmacher U; Trautwein C; Bruns T; Stallmach A
    Am J Transplant; 2020 Nov; 20(11):3042-3050. PubMed ID: 32515125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Vaccination and Early Monoclonal Antibody Therapy on Coronavirus Disease 2019 Outcomes in Organ Transplant Recipients During the Omicron Wave.
    Solera JT; Árbol BG; Alshahrani A; Bahinskaya I; Marks N; Humar A; Kumar D
    Clin Infect Dis; 2022 Dec; 75(12):2193-2200. PubMed ID: 35445690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 Outcomes Among Solid Organ Transplant Recipients: A Case-control Study.
    Sharma P; Chen V; Fung CM; Troost JP; Patel VN; Combs M; Norman S; Garg P; Colvin M; Aaronson K; Sonnenday CJ; Golob JL; Somers EC; Doshi MM
    Transplantation; 2021 Jan; 105(1):128-137. PubMed ID: 32890139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and predictors of SARS-CoV-2 antibodies among solid organ transplant recipients with confirmed infection.
    Burack D; Pereira MR; Tsapepas DS; Harren P; Farr MA; Arcasoy S; Cohen DJ; Mohan S; Emond JC; Hod EA; Verna EC
    Am J Transplant; 2021 Jun; 21(6):2254-2261. PubMed ID: 33590675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction in the risk of progression of solid organ transplant recipients infected by SARS-CoV-2 treated with monoclonal antibodies.
    Candel FJ; Salavert M; Lorite Mingot D; Manzano Crespo M; Pérez Portero P; Cuervo Pinto R
    Rev Esp Quimioter; 2023 Aug; 36(4):380-391. PubMed ID: 37089055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of solid organ transplant status on outcomes of hospitalized patients with COVID-19 infection.
    Schaenman J; Byford H; Grogan T; Motwani Y; Beaird OE; Kamath M; Lum E; Meneses K; Sayah D; Vucicevic D; Saab S
    Transpl Infect Dis; 2022 Aug; 24(4):e13853. PubMed ID: 35579437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence and severity of SARS-CoV-2 infections in liver and kidney transplant recipients in the post-vaccination era: Real-life data from Denmark.
    Hamm SR; Rezahosseini O; Møller DL; Loft JA; Poulsen JR; Knudsen JD; Pedersen MS; Schønning K; Harboe ZB; Rasmussen A; Sørensen SS; Nielsen SD
    Am J Transplant; 2022 Nov; 22(11):2637-2650. PubMed ID: 35801693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19 in solid organ transplant recipients: a single-center experience.
    Hoek RAS; Manintveld OC; Betjes MGH; Hellemons ME; Seghers L; Van Kampen JAA; Caliskan K; van de Wetering J; van den Hoogen M; Metselaar HJ; Hesselink DA;
    Transpl Int; 2020 Sep; 33(9):1099-1105. PubMed ID: 32460390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-19 mortality may be reduced among fully vaccinated solid organ transplant recipients.
    Sandoval M; Nguyen DT; Huang HJ; Yi SG; Ghobrial RM; Gaber AO; Graviss EA
    PLoS One; 2022; 17(12):e0279222. PubMed ID: 36542654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breakthrough COVID-19 after SARS-CoV-2 vaccination in solid organ transplant recipients: An analysis of symptomatic cases and monoclonal antibody therapy.
    Yetmar ZA; Bhaimia E; Bierle DM; Ganesh R; Razonable RR
    Transpl Infect Dis; 2022 Apr; 24(2):e13779. PubMed ID: 34932874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19 in Solid Organ Transplantation: Disease Severity and Clinical Update.
    Arya A; Li M; Aburjania N; Singh P; Royer T; Moss S; Belden KA
    Transplant Proc; 2021 May; 53(4):1227-1236. PubMed ID: 33757628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.